img

Global Anti-Ageing Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Ageing Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
Anti-Ageing Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Ageing Drugs market is projected to reach US$ 140690 million in 2034, increasing from US$ 82060 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Skin and Hair are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Ageing Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Ageing Drugs key manufacturers include Nu Skin, BIOTIME, Elysium Health, La Roche-Posay and DermaFix, etc. Nu Skin, BIOTIME, Elysium Health are top 3 players and held % sales share in total in 2022.
Anti-Ageing Drugs can be divided into Hormonal Therapy, Antioxidants, Enzymes and Stem Cells, etc. Hormonal Therapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Ageing Drugs is widely used in various fields, such as Skin, Hair and Others,, etc. Skin provides greatest supports to the Anti-Ageing Drugs industry development. In 2022, global % sales of Anti-Ageing Drugs went into Skin filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Ageing Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Segment by Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others

Segment by Application


Skin
Hair
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-Ageing Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Ageing Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Ageing Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Ageing Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Ageing Drugs introduction, etc. Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Ageing Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anti-Ageing Drugs Market Overview
1.1 Anti-Ageing Drugs Product Overview
1.2 Anti-Ageing Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Antioxidants
1.2.3 Enzymes
1.2.4 Stem Cells
1.2.5 Others
1.3 Global Anti-Ageing Drugs Market Size by Type
1.3.1 Global Anti-Ageing Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Ageing Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Ageing Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Ageing Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Ageing Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Ageing Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Type (2018-2024)
2 Global Anti-Ageing Drugs Market Competition by Company
2.1 Global Top Players by Anti-Ageing Drugs Sales (2018-2024)
2.2 Global Top Players by Anti-Ageing Drugs Revenue (2018-2024)
2.3 Global Top Players by Anti-Ageing Drugs Price (2018-2024)
2.4 Global Top Manufacturers Anti-Ageing Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Ageing Drugs Market Competitive Situation and Trends
2.5.1 Anti-Ageing Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Ageing Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
2.8 Key Manufacturers Anti-Ageing Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Ageing Drugs Status and Outlook by Region
3.1 Global Anti-Ageing Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Ageing Drugs Historic Market Size by Region
3.2.1 Global Anti-Ageing Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Ageing Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Ageing Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Ageing Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Ageing Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Ageing Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Ageing Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Ageing Drugs by Application
4.1 Anti-Ageing Drugs Market Segment by Application
4.1.1 Skin
4.1.2 Hair
4.1.3 Others
4.2 Global Anti-Ageing Drugs Market Size by Application
4.2.1 Global Anti-Ageing Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Ageing Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Ageing Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Ageing Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Ageing Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Ageing Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Application (2018-2024)
5 North America Anti-Ageing Drugs by Country
5.1 North America Anti-Ageing Drugs Historic Market Size by Country
5.1.1 North America Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Ageing Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Ageing Drugs Sales in Value by Country (2018-2024)
5.2 North America Anti-Ageing Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Ageing Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Ageing Drugs Sales in Value by Country (2024-2034)
6 Europe Anti-Ageing Drugs by Country
6.1 Europe Anti-Ageing Drugs Historic Market Size by Country
6.1.1 Europe Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Ageing Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Ageing Drugs Sales in Value by Country (2018-2024)
6.2 Europe Anti-Ageing Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Ageing Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Ageing Drugs by Region
7.1 Asia-Pacific Anti-Ageing Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Ageing Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2024-2034)
8 Latin America Anti-Ageing Drugs by Country
8.1 Latin America Anti-Ageing Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Ageing Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Ageing Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Ageing Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Ageing Drugs by Country
9.1 Middle East and Africa Anti-Ageing Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Ageing Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Nu Skin
10.1.1 Nu Skin Company Information
10.1.2 Nu Skin Introduction and Business Overview
10.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Nu Skin Anti-Ageing Drugs Products Offered
10.1.5 Nu Skin Recent Development
10.2 BIOTIME
10.2.1 BIOTIME Company Information
10.2.2 BIOTIME Introduction and Business Overview
10.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 BIOTIME Anti-Ageing Drugs Products Offered
10.2.5 BIOTIME Recent Development
10.3 Elysium Health
10.3.1 Elysium Health Company Information
10.3.2 Elysium Health Introduction and Business Overview
10.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Elysium Health Anti-Ageing Drugs Products Offered
10.3.5 Elysium Health Recent Development
10.4 La Roche-Posay
10.4.1 La Roche-Posay Company Information
10.4.2 La Roche-Posay Introduction and Business Overview
10.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 La Roche-Posay Anti-Ageing Drugs Products Offered
10.4.5 La Roche-Posay Recent Development
10.5 DermaFix
10.5.1 DermaFix Company Information
10.5.2 DermaFix Introduction and Business Overview
10.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 DermaFix Anti-Ageing Drugs Products Offered
10.5.5 DermaFix Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Ageing Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Ageing Drugs Industrial Chain Analysis
11.4 Anti-Ageing Drugs Market Dynamics
11.4.1 Anti-Ageing Drugs Industry Trends
11.4.2 Anti-Ageing Drugs Market Drivers
11.4.3 Anti-Ageing Drugs Market Challenges
11.4.4 Anti-Ageing Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Ageing Drugs Distributors
12.3 Anti-Ageing Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hormonal Therapy
Table 2. Major Company of Antioxidants
Table 3. Major Company of Enzymes
Table 4. Major Company of Stem Cells
Table 5. Major Company of Others
Table 6. Global Anti-Ageing Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Anti-Ageing Drugs Sales by Type (2018-2024) & (K Units)
Table 8. Global Anti-Ageing Drugs Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Anti-Ageing Drugs Sales by Type (2018-2024) & (US& Million)
Table 10. Global Anti-Ageing Drugs Market Share in Value by Type (2018-2024)
Table 11. Global Anti-Ageing Drugs Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Anti-Ageing Drugs Sales by Type (2024-2034) & (K Units)
Table 13. Global Anti-Ageing Drugs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Anti-Ageing Drugs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Anti-Ageing Drugs Sales Market Share in Value by Type (2024-2034)
Table 16. Global Anti-Ageing Drugs Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Anti-Ageing Drugs Sales by Type (2018-2024) & (K Units)
Table 18. North America Anti-Ageing Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Anti-Ageing Drugs Sales (K Units) by Type (2018-2024)
Table 20. Europe Anti-Ageing Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Anti-Ageing Drugs Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Anti-Ageing Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Anti-Ageing Drugs Sales (K Units) by Type (2018-2024)
Table 24. Latin America Anti-Ageing Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Anti-Ageing Drugs Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Anti-Ageing Drugs Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Anti-Ageing Drugs Sales by Company (2018-2024) & (K Units)
Table 28. Global Anti-Ageing Drugs Sales Share by Company (2018-2024)
Table 29. Global Anti-Ageing Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Anti-Ageing Drugs Revenue Share by Company (2018-2024)
Table 31. Global Market Anti-Ageing Drugs Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Anti-Ageing Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Anti-Ageing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
Table 36. Key Manufacturers Anti-Ageing Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Anti-Ageing Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Anti-Ageing Drugs Sales by Region (2018-2024) & (K Units)
Table 40. Global Anti-Ageing Drugs Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Anti-Ageing Drugs Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Anti-Ageing Drugs Sales Market Share in Value by Region (2018-2024)
Table 43. Global Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Anti-Ageing Drugs Sales by Region (2024-2034) & (K Units)
Table 45. Global Anti-Ageing Drugs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Anti-Ageing Drugs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Anti-Ageing Drugs Sales Market Share in Value by Region (2024-2034)
Table 48. Global Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Anti-Ageing Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Anti-Ageing Drugs Sales by Application (2018-2024) & (K Units)
Table 51. Global Anti-Ageing Drugs Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Anti-Ageing Drugs Sales Market Share in Value by Application (2018-2024)
Table 54. Global Anti-Ageing Drugs Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Anti-Ageing Drugs Sales by Application (2024-2034) & (K Units)
Table 56. Global Anti-Ageing Drugs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Anti-Ageing Drugs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Anti-Ageing Drugs Sales Market Share in Value by Application (2024-2034)
Table 59. Global Anti-Ageing Drugs Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Anti-Ageing Drugs Sales by Application (2018-2024) (K Units)
Table 61. North America Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Anti-Ageing Drugs Sales by Application (2018-2024) (K Units)
Table 63. Europe Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Anti-Ageing Drugs Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Anti-Ageing Drugs Sales by Application (2018-2024) (K Units)
Table 67. Latin America Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Anti-Ageing Drugs Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Anti-Ageing Drugs Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Anti-Ageing Drugs Sales by Country (2018-2024) & (K Units)
Table 71. North America Anti-Ageing Drugs Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Anti-Ageing Drugs Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Anti-Ageing Drugs Sales Market Share in Value by Country (2018-2024)
Table 74. North America Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 75. North America Anti-Ageing Drugs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Anti-Ageing Drugs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Anti-Ageing Drugs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Anti-Ageing Drugs Sales by Country (2018-2024) & (K Units)
Table 79. Europe Anti-Ageing Drugs Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Anti-Ageing Drugs Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Anti-Ageing Drugs Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 83. Europe Anti-Ageing Drugs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Anti-Ageing Drugs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Anti-Ageing Drugs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Anti-Ageing Drugs Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Anti-Ageing Drugs Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Anti-Ageing Drugs Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Anti-Ageing Drugs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Anti-Ageing Drugs Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Anti-Ageing Drugs Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Anti-Ageing Drugs Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Anti-Ageing Drugs Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Anti-Ageing Drugs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Anti-Ageing Drugs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Anti-Ageing Drugs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Anti-Ageing Drugs Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Anti-Ageing Drugs Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Anti-Ageing Drugs Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Anti-Ageing Drugs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Value by Country (2024-2034)
Table 110. Nu Skin Company Information
Table 111. Nu Skin Introduction and Business Overview
Table 112. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Nu Skin Anti-Ageing Drugs Product
Table 114. Nu Skin Recent Development
Table 115. BIOTIME Company Information
Table 116. BIOTIME Introduction and Business Overview
Table 117. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. BIOTIME Anti-Ageing Drugs Product
Table 119. BIOTIME Recent Development
Table 120. Elysium Health Company Information
Table 121. Elysium Health Introduction and Business Overview
Table 122. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Elysium Health Anti-Ageing Drugs Product
Table 124. Elysium Health Recent Development
Table 125. La Roche-Posay Company Information
Table 126. La Roche-Posay Introduction and Business Overview
Table 127. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. La Roche-Posay Anti-Ageing Drugs Product
Table 129. La Roche-Posay Recent Development
Table 130. DermaFix Company Information
Table 131. DermaFix Introduction and Business Overview
Table 132. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. DermaFix Anti-Ageing Drugs Product
Table 134. DermaFix Recent Development
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Anti-Ageing Drugs Market Trends
Table 138. Anti-Ageing Drugs Market Drivers
Table 139. Anti-Ageing Drugs Market Challenges
Table 140. Anti-Ageing Drugs Market Restraints
Table 141. Anti-Ageing Drugs Distributors List
Table 142. Anti-Ageing Drugs Downstream Customers
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Ageing Drugs Product Picture
Figure 2. Global Anti-Ageing Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Ageing Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Ageing Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Hormonal Therapy
Figure 6. Global Hormonal Therapy Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Antioxidants
Figure 8. Global Antioxidants Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Enzymes
Figure 10. Global Enzymes Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Stem Cells
Figure 12. Global Stem Cells Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Anti-Ageing Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Anti-Ageing Drugs Sales Market Share by Type in 2022 & 2034
Figure 17. North America Anti-Ageing Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Anti-Ageing Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Anti-Ageing Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Anti-Ageing Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Anti-Ageing Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Anti-Ageing Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Ageing Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Ageing Drugs Revenue in 2022
Figure 29. Anti-Ageing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Skin
Figure 31. Global Skin Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Hair
Figure 33. Global Hair Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Anti-Ageing Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Anti-Ageing Drugs Sales Market Share by Application in 2022 & 2034
Figure 38. North America Anti-Ageing Drugs Sales Market Share in Volume by Application in 2022
Figure 39. North America Anti-Ageing Drugs Sales Market Share in Value by Application in 2022
Figure 40. Europe Anti-Ageing Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Europe Anti-Ageing Drugs Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Anti-Ageing Drugs Sales Market Share in Value by Application in 2022
Figure 44. Latin America Anti-Ageing Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Anti-Ageing Drugs Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Anti-Ageing Drugs Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Anti-Ageing Drugs Manufacturing Cost Structure
Figure 49. Anti-Ageing Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed